Informationes plurimae ― Latine

Scleroderma, morbus rarus, circa telae notam afficit, ostendens cutem induratam et alias partes corporis interdum impactas. Duo genera principalia sunt: systemic sclerosis, quae cutem duritiam et viscera interiora involvit, ac localized scleroderma, quae etiam morphea nota est, quae proprie cuti et fibris subest circumscripta, cum cursu benigne et auto‑limitato. Etiam si sclerodermia localis rara est et eius causa obscura, recentissima investigatio suadet quod potest etiam organa interna afficere et varias quaestiones sanitatis provocare. Praematura curatio pendet ne impedimenta, gravitate potentiae sclerodermiae localis, ponatur.
Scleroderma is a rare connective tissue disease that is manifested by cutaneous sclerosis and variable systemic involvement. Two categories of scleroderma are known: systemic sclerosis, characterized by cutaneous sclerosis and visceral involvement, and localized scleroderma or morphea which classically presents benign and self-limited evolution and is confined to the skin and/or underlying tissues. Localized scleroderma is a rare disease of unknown etiology. Recent studies show that the localized form may affect internal organs and have variable morbidity. Treatment should be started very early, before complications occur due to the high morbidity of localized scleroderma.

Morphea, etiam scleroderma locale notum, rara morbus autoimmune est, textum connectens afficiens. Variis modis se manifestare potest, et non est admodum commune, cum incidens 0,4–2,7 per 100 000 hominum quolibet anno. Morphea saepe inter 2 et 14 annos apparere solet, et puellas saepius quam pueros afficit.
Morphea (localized scleroderma) is a rare autoimmune connective tissue disease with variable clinical presentations, with an annual incidence of 0.4-2.7 cases per 100,000. Morphea occurs most frequently in children aged 2-14 years, and the disease exhibits a female predominance.